75F40126C00223↗

Lanevis, L.L.C received this contract from Fda Office of Acq Grant Svcs, Food and Drug Administration: $498.1K obligated so far for it and telecom - business application/application development software as a service. It runs to 2027-09-29, or to 2029-03-26 if every option is exercised.

Key facts · data as of Oct 28, 2026

Recipient
Lanevis, L.L.C
Awarding agency
Food and Drug Administration (Department of Health and Human Services)
Contracting office
Fda Office of Acq Grant Svcs (75F401)
Obligated to date
$498.1K
Potential value
$1.48M
Ends
2027-09-29

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 28, 2026.

Cite this page: SpendQuery, Award 75F40126C00223, data as of Oct 28, 2026, https://spendquery.com/award?id=CONT_AWD_75F40126C00223_7524_-NONE-_-NONE-

SUPPORT FOR RARE DISEASE INNOVATION HUB

Definitive Contract · Food and Drug Administration · to Lanevis, L.L.C (UEI UJSBWLVVB5K7) · data as of 2026-10-28

Obligated to date$498.1K1 action
Current value$498.1Kwith options exercised
Potential value$1.48Mif every option is used
Period2026-09-30 → 2027-09-29up to 2029-03-26 with options

Up for re-bid: ends 2027-09-29. Recompete brief →

What it is

Product or service
IT and Telecom - Business Application/Application Development Software As a Service (PSC DA10)
Industry
Computer Systems Design Services (NAICS 541512)
Contracting office
Fda Office of Acq Grant Svcs (75F401)
Competition
Not available for competition · 1 offer received
Set-aside
8(a) sole source
Pricing
Labor hours
How it was bought
Standalone contract
Where the work is
Montgomery, MD · district MD-08

Obligations by fiscal year

FY2026$498.1K

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

1 action since 2026-09-30. Each is a modification or amendment with the money it added or took back.

DateModificationKindAmountWhat the agency wrote
2026-09-300$498.1KSUPPORT FOR RARE DISEASE INNOVATION HUB

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-28). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗